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Abstract
The transport of cGMP out of cells is energy requiring and has characteristics compatible with an ATP-energised anion
pump. In the present study a model with inside-out vesicles from human erythrocytes was employed for further
characterisation of the cGMP transporter. The uptake of leukotriene C4 (LTC4), a substrate for multidrug resistance protein
(MRP), was concentration-dependently inhibited by the leukotriene antagonist MK571 (IC50 = 110 þ 20 nM), but cGMP was
unable to inhibit LTC4 uptake. Oxidised glutathione (GSSG) and glutathione S-conjugates caused a concentration-
dependent inhibition of [3H]cGMP uptake with IC50 of 2200 þ 700 WM for GSSG, 410 þ 210 WM for S-(p-
nitrobenzyl)glutathione and 37 þ 16 WM for S-decylglutathione, respectively. Antioxidants such as reduced glutathione
and dithiothreitol did not influence transport for concentrations up to 100 WM, but both inhibited cGMP uptake with
approx. 25% at 1 mM. The cGMP pump was sensitive to temperature without activity below 20‡C. The transport of cGMP
was dependent on pH with maximal activity between pH 8.0 and 8.5. Calcium caused a concentration-dependent inhibition
with IC50 of 43 þ 12 WM. Magnesium gave a marked activation in the range between 1 and 20 mM with maximum effect at 10
mM. The other divalent cations, Mn2 and Co2, were unable to substitute Mg2, but caused some activation at 1 mM.
EDTA and EGTA stimulated cGMP transport concentration-dependently with 50% and 100% above control at 100 WM,
respectively. The present study shows that the cGMP pump has properties compatible with an organic anion transport
ATPase, without affinity for the MRP substrate LTC4. However, the blockade of the cGMP transporter by glutathione S-
conjugates suggests it is one of several GS-X pumps. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cellular e¥ux of cGMP is e¡ected by a specialised
transport system. Secretion of cGMP has been
shown to be unidirectional, to occur against a gra-
dient of high levels of extracellular cGMP [1^4] and
to be temperature-sensitive [1,5,6]. These results are
compatible with an energy-requiring transport sys-
tem. Furthermore, it has been shown that cGMP
transport was dependent on ATP [7], ATP hydrolysis
[8] and inhibited by well-known ATPase inhibitors
[9]. Several studies which have shown that probene-
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cid inhibits cGMP e¥ux [1,5,6,8,10^14] suggest that
the cGMP pump is an anion transporter. This is a
property in common with MRP (multidrug resistance
protein) [15]. The 190 kDa MRP has been associated
with the transport of cysteinyl leukotrienes, such as
LTC4 (leukotriene C4), and several glutathione S-
conjugates [16]. MRP has been detected in human
erythrocyte membranes by the use of monoclonal
antibodies [17] and identi¢ed in these cells as the
glutathione S-conjugate export pump [18]. However,
the expansion of the MRP family makes the compre-
hension of GS-X pumps more complex [19].
The present study was undertaken for further
characterisation of the active cGMP transport: ¢rst,
to determine whether LTC4, GSSG (oxidised gluta-
thione), SDG (S-decylglutathione), SPNBG (S-(p-ni-
trobenzyl)glutathione) and cGMP have a common
ATP-dependent transport system; second, to exam-
ine the e¡ect of the antioxidants GSH (reduced glu-
tathione) and DTT (dithiothreitol) on cGMP trans-
port; third, to study how temperature, pH and
divalent ions (Mg2, Ca2, Mn2 and Co2) and
chelators (EDTA and EGTA) a¡ect the uptake of
cGMP to inside-out vesicles from human erythro-
cytes.
2. Materials and methods
2.1. Chemicals
[3H]cGMP (spec. act. 16 Ci/mmol) and [3H]LTC4
(spec. act. 115 Ci/mmol) were purchased from Amer-
sham International (Buckinghamshire, UK) and Du
Pont NEN (Boston, MA), respectively. EGTA,
EDTA, DTT, GSH, GSSG, SPNBG, SDG and
ATP were all obtained from Sigma (St. Louis,
MO). MK571 was a kind gift from Merck Sharp
and Dome (Drammen, Norway). Other chemicals
were of analytical grade.
2.2. Bu¡ers
The following bu¡ers were employed for prepara-
tion and incubation of inside-out vesicles: bu¡er A:
3 mM KCl, 110 mM NaCl and 5 mM Tris-HCl (pH
8.0^8.2); bu¡er B: 3 mM KCl and 5 mM Tris-HCl
(pH 8.0^8.2); bu¡er C: 140 mM NaCl, 3 mM KCl,
10 mM Na2HPO4 and 1.8 mM KH2PO4 (pH 7.3^
7.4).
2.3. Blood sampling and preparation of inside-out
vesicles
Inside-out vesicles were prepared from fresh hu-
man blood and all procedures were performed at
4‡C. Venous blood (10 ml) was drawn into EDTA
vacuum tubes (Vacutainer, Becton Dikinson, Mey-
land Cedex, France). The cells were separated from
plasma by centrifugation (1000Ug for 15 min),
washed four times with bu¡er A, the last one with
4 ml packed cells in 20 ml bu¡er. The cells were lysed
in bu¡er B (4 ml packed cells in 20 ml bu¡er). The
ghosts were sedimented (20 000Ug for 10 min) before
resuspension in bu¡er B (1 ml in 20 ml). This proce-
dure was repeated until the membranes appeared
milky white with a clear supernatant. The membrane
vesiculation was initiated when the ghost pellet (1 ml)
was resuspended in 0.5 mM Tris-HCl (1 ml), pH 8.0^
8.2, and left for 2 h at 0^4‡C. The membranes were
sedimented (100 000Ug for 30 min), then mixed with
0.5 mM Tris-HCl (1 ml), pH 8.0^8.2, and passed ¢ve
times through a 20 mm long 27-gauge needle. The
mixture of vesicles and ghosts were diluted with an-
other 1 ml of 0.5 mM Tris-HCl, pH 8.0^8.2 and
layered above a linear gradient with densities from
1.05 to 1.15 g/ml with Nycodenz (Nycomed Pharma,
Oslo, Norway). The vesicles and ghosts were the
separated during centrifugation for 16^17 h at
100 000Ug at 0^4‡C. The layer with the inside-out
vesicles was washed with 40 vols. of bu¡er C, sedi-
mented at 28 000Ug for 30 min and ¢nally resus-
pended in 0.7^0.8 ml bu¡er C.
2.4. Uptake studies
The experiments were performed at 37‡C (if not
otherwise stated) with 50^300 Wg protein in 400 Wl
bu¡er C, pH 7.4 (if not otherwise stated), including
10 mM MgCl2 (if not otherwise stated), 1 WM
[3H]cGMP, with or without 1 mM ATP. The uptake
of radioligand was terminated by addition of 10 ml
ice-cold 30 mM NaF/0.5 mM Tris-HCl. After centri-
fugation at 16 300Ug the vesicles were washed once
with another 10 ml of this mixture, and after a ¢nal
centrifugation mixed with 1 ml ice-cold water and
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frozen. After 18 h at 320‡C, the mixture was
thawed, transferred to Eppendorf tubes and centri-
fuged at 15 000Ug for 30 min. The radioactivity was
determined in 800 Wl supernatant transferred to 10
ml Ultima Gold XR (Packard, Groningen, The
Netherlands) in a 1900 TR liquid scintillation analy-
ser (Packard, Meridian, MS).
2.5. Radiochemical purity
The radioactivity taken up in the inside-out
vesicles was examined with thin-layer chromatogra-
phy as previously described [7]. It showed a single
band with identical Rf value as the native radioiso-
tope.
2.6. Sidedness
The orientation of the vesicles was ensured using
acetylcholinesterase activity as a plasma membrane
outside marker as reported recently [8].
2.7. Protein concentrations
Protein concentrations were determined by the
Coomassie blue method [20] with reagents from
Bio-Rad laboratories (Richmond, CA) and BSA
from Sigma as standards.
2.8. Statistics
Paired t-tests were performed using GraphPad In-
Stat version 3.00 for Windows 95 (GraphPad Soft-
ware, San Diego, CA, USA).
3. Results
3.1. E¡ect of MK571 and cGMP on [3H]LTC4
transport
LTC4 transport was inhibited by the LTD4 recep-
tor antagonist MK571 in a concentration-dependent
mode (Fig. 1). Under these experimental conditions
the concentration (IC50) that reduced LTC4 uptake
to 50% was determined according to Chou [21]. The
uptake was de¢ned as the di¡erence in the amount
LTC4 associated with the vesicles in the presence and
absence of 1 mM ATP. The analysis gave an IC50
value of 110 þ 20 nM (mean þ S.E.M., n = 3). For
concentrations up to 10 WM cGMP was unable to
inhibit LTC4 uptake (Fig. 1). At 100 WM the trans-
port was reduced to 91 þ 2% of control (mean þ
S.E.M., n = 3, P6 0.05 paired two-tailed t-test).
3.2. E¡ect of GSSG, SPNBG and SDG on
[3H]cGMP transport
The ability of GSSG and glutathione S-conjugates
to inhibit the uptake of cGMP was investigated. The
uptake was de¢ned as the di¡erence in the amount of
cGMP associated with the vesicles in the presence
and absence of 1 mM ATP. Fig. 2 shows that
Fig. 1. The ability of cGMP and MK571 to inhibit [3H]LTC4
uptake to inside-out vesicles after 120 min co-incubation at
37‡C. Concentrations of MK571 (b) and cGMP (R) from 0.01
to 100 WM were added together with 1 WM [3H]cGMP with or
without 1 mM ATP. The results are presented as mean þ
S.E.M. (n = 3).
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GSSG had no marked e¡ect below 100 WM, but from
100 WM to 1 mM, the uptake was reduced from
87 þ 3% to 53 þ 9% of control (mean þ S.E.M.,
n = 8). Two glutathione S-conjugates were also tested
for their ability to reduce cGMP uptake. SPNBG
and SDG were more potent inhibitors than GSSG
(Fig. 2). Under these experimental conditions the
concentration (IC50) that reduced uptake to 50%
was determined according to Chou [21]. The IC50
values (mean þ S.E.M.) were 2200 þ 700 WM (n = 8)
for GSSG, 410 þ 210 WM (n = 4) for SPNBG and
37 þ 16 WM for SDG (n = 4).
3.3. E¡ect of antioxidants on [3H]cGMP transport
GSH and DTT showed a concentration-dependent
reduction in the uptake (Table 1). However, a signi¢-
cant reduction in the transport of cGMP was seen
only for the highest tested concentration (1 mM).
3.4. E¡ect of temperature on [3H]cGMP transport
and binding
We studied the temperature sensitivity of cGMP
uptake for temperatures ranging from 0^4‡C to
37‡C. The uptake increased linearly with temperature
above 20‡C and no uptake occurred below this tem-
perature (Fig. 3). At 15‡C there was no di¡erence in
the association in the presence and absence of ATP
(Table 2).
The binding of cGMP to the inside-out vesicles
(association in the absence of ATP) reached an equi-
librium within 15 min for temperatures between 15
and 37‡C. At 0^4‡C a slower association was ob-
served (results not shown). The binding of cGMP
(association to inside-out vesicles in the absence of
ATP) in the absence of ATP was not dependent on
temperature (Table 2). After 120 min incubation at
0^4‡C, ATP apparently inhibited the binding of
cGMP (Table 2).
3.5. E¡ect of pH on [3H]cGMP transport
The present data demonstrate that the cGMP up-
take was pH-sensitive with a maximal accumulation
Table 1
E¡ect of antioxidants on [3H]cGMP uptake to inside-out
vesicles
Conc. (WM) Uptake of [3H]cGMP (% of control)
GSH DTT
1 98 þ 3 (n = 3)ns 95 þ 3 (n = 3)ns
10 95 þ 2 (n = 3)ns 92 þ 4 (n = 3)ns
100 86 þ 2 (n = 7)ns 90 þ 4 (n = 4)ns
1000 75 þ 2 (n = 4)** 76 þ 5 (n = 5)*
The inside-out vesicles were co-incubated with [3H]cGMP and
GSH or DTT for 120 min at 37‡C. The results are presented as
mean þ S.E.M.
*Paired t-test, two-tailed P-value: nsPs 0.05, *P6 0.025,
**P6 0.001.
Fig. 2. The e¡ect of GSSG, SPNBG and SDG on [3H]cGMP
on the uptake of cGMP to inside-out vesicles after 120 min co-
incubation at 37‡C. Concentrations of GSSG (b), SPNB-gluta-
thione (R) and SD-glutathione (F) from 0.1 WM to 1 mM were
added together with 1 WM [3H]cGMP with or without 1 mM
ATP. The results are presented as mean þ S.E.M. (n = 4).
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at pH 8.0^8.5 (Fig. 4). The amount of cGMP taken
up after 120 min at pH 7.5 was 43.3 þ 9.8 dpm/Wg
protein (mean þ S.E.M., n = 6). The uptake at pH 7.1
and 8.0 was 27 þ 8% (P6 0.05) lower and 24 þ 5%
higher (P6 0.05) than that observed at pH 7.5
(mean þ S.E.M., n = 6). The di¡erence between the
uptake at pH 8.0 and 8.5 was not statistically signi¢-
cant (Ps 0.05). The cGMP binding was una¡ected
by pH (Ps 0.05 compared to the value at pH 7.5)
with the exception of a marked reduction at pH 6
(approx. 85% below the value at pH 7.5, data not
shown).
3.6. E¡ect of divalent ions on [3H]cGMP transport
and binding
Calcium inhibited the transport of cGMP in a con-
centration-dependent manner at 37‡C (Fig. 5).
Under these experimental conditions the concen-
tration (IC50) that reduced uptake to 50% was deter-
mined according to Chou [21] and gave a value of
43 þ 12 WM (mean þ S.E.M., n = 9). Calcium had no
concentration-dependent e¡ects on the binding of
cGMP at 37‡C or at 0^4‡C (results not shown).
Fig. 6 (left panel) shows that the divalent cations
Table 2
Association of [3H]cGMP (1 WM) to inside-out vesicles in the presence and absence of ATP (1 mM) at 15 and 4‡C after 15 and 120
min co-incubation
Temperature Binding/uptake of cGMP (dpm/Wg protein)
After 15 min After 120 min
+ATP 3ATP +ATP 3ATP
37‡Ca 11.5 þ 0.7 7.9 þ 1.6** 41.8 þ 4.5 7.9 þ 1.6**
15‡Cb 8.2 þ 0.8 8.1 þ 1.2ns 8.4 þ 1.1 8.1 þ 1.3ns
0^4‡Cb 6.3 þ 0.9 7.4 þ 0.4ns 7.5 þ 0.9 8.4 þ 0.7*
The results are presented as mean þ S.E.M.
Di¡erence between association with and without ATP. Paired t-test with two-tailed P-value: nsPs 0.5, *P6 0.02, **P6 0.005.
aSix separate experiments.
bFive separate experiments.
Fig. 3. The e¡ect of temperature on the uptake of cGMP to inside-out vesicles from 15 to 120 min. The vesicles were incubated with
1 WM [3H]cGMP with and without 1 mM ATP. Left panel: accumulation of cGMP at 22‡C (F, n = 4), 27‡C (S, n = 6), 32‡C (R,
n = 4) and 37‡C (b, n = 6) is presented as mean values. Right panel : correlation between uptake and temperature after 120 min incuba-
tion, y = a*x+b where a = 1.95 and b =338.6, r = 0.996, P6 0.005. The regression line intercepts with the abscissa at 19.7‡C.
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Mg2, Mn2 and Co2 were activators of the cGMP
uptake, but with a di¡erent pro¢le. Magnesium was
markedly more potent and showed an activation for
a much broader concentration range as compared
with Mn2 and Co2. The maximum activation
(1180 þ 400% above control, mean þ S.E.M., n = 5)
was seen at Mg2 concentrations of 8^10 mM
(P6 0.05, paired t-test, two-tailed P-value). The
maximum activation for Mn2 and Co2, observed
at 1 mM, was 600 þ 60% (P6 0.001) and 530 þ 70%
(P6 0.01) above control (mean þ S.E.M., n = 5,
paired t-test, two-tailed P-value), respectively. With
increasing concentrations of the divalent cations, the
activation diminished (Fig. 6, left panel). At the high-
est Mg2 concentration tested (20 mM), some acti-
vation (590 þ 240% above control) appeared to exist,
but the elevation was not statistically signi¢cant
(Ps 0.05, paired t-test, two-tailed P-value). The
two other divalent cations (20 mM) seemed to reduce
the transport below the control situation, but
the reductions were not statistically signi¢cant
(Ps 0.05, paired t-test, two-tailed P-value) with val-
ues of 69 þ 40% and 53 þ 18% (mean þ S.E.M., n = 5)
of control for Mn2 and Co2, respectively.
The binding of cGMP to the membrane endoside
was also a¡ected di¡erently by the divalent ions. No
e¡ect was seen in the presence of Mg2 (20 mM)
with a binding of 95 þ 8% (mean þ S.E.M., n = 5) of
control (Ps 0.05, paired t-test, two-tailed P-value).
In contrast, Mn2 and Co2 caused a concentration-
dependent inhibition of binding (Fig. 6, right panel).
At the highest concentration tested (20 mM) these
ions reduced the binding to 34 þ 8% and 34 þ 7%
(mean þ S.E.M., n = 5) of control for Mn2 and
Co2, respectively. This e¡ect was highly signi¢cant
(P6 0.005, paired t-test, two-tailed P-value).
Fig. 5. The e¡ect of Ca2 on the uptake of cGMP to inside-out
vesicles after 120 min co-incubation at 37‡C. Concentrations of
calcium from 0.1 WM to 10 mM were added together with 1 WM
[3H]cGMP with or without 1 mM ATP. The results are pre-
sented as mean þ S.E.M. of nine separate experiments.
Fig. 4. The e¡ect of pH on the uptake of cGMP to inside-out
vesicles after 120 min incubation at 37‡C. The vesicles were in-
cubated with 1 WM [3H]cGMP with and without 1 mM ATP.
Accumulation of cGMP is given relative to the values obtained
at pH 7.4 (mean þ S.E.M., n = 6).
BBAMEM 77728 28-12-99
E. Sundkvist et al. / Biochimica et Biophysica Acta 1463 (2000) 121^130126
3.7. E¡ect of EGTA and EDTA on [3H]cGMP
transport and binding
Fig. 7 shows that both EDTA and EGTA in-
creased the cGMP uptake in a concentration-depend-
ent mode. EGTA was more potent than EDTA
which appeared to reach a plateau at 10 WM. For a
chelator concentration of 100 WM, the uptake of
cGMP was 50 þ 10% (mean þ S.E.M., n = 3, one-
tailed P6 0.05) and 100 þ 20% (mean þ S.E.M.,
n = 4, one-tailed P6 0.025) above control for
EDTA and EGTA, respectively. The binding of
cGMP to the vesicles was not in£uenced (data not
shown).
4. Discussion
The transport of molecules across lipid membranes
is an essential function of all living organisms. The
plasma membrane is virtually impermeable to extra-
cellular cyclic nucleotides in physiological concentra-
tions, but the appearance of these intracellular signal
molecules in extracellular £uids has been known for
decades. Evidence exists that the transport system for
cGMP is closely linked to an ATPase since ATP, but
not the non-hydrolysable ATP analogues ATP-Q-S
and AMP-PNP, promotes cGMP transport [8].
This idea is also supported by the observations that
well-known ATPase inhibitors caused a concentra-
tion-dependent reduction in the cGMP transport
[9]. These observations suggest that the cGMP
pump is a member of the ATP-dependent organic
ion transporters, such as P-glycoprotein and MRP.
Unlike P-glycoprotein, but similar to MRP, the non-
selective inhibitor of anion transport systems, probe-
necid, inhibits the cGMP pump [1,5,6,8,10^14].
In the present study we investigated the possibility
that the cGMP was transported by MRP. The ¢nd-
ing that cGMP was unable to inhibit LTC4 transport
strongly suggests that two non-identical transport
routes exist, since LTC4 has been identi¢ed as an
endogenous substrate with high a⁄nity for MRP
[15]. However, the ability of the LTD4 receptor an-
tagonist MK571 to reduce the uptake of LTC4 to
inside-out vesicles in a concentration-dependent
mode is in agreement with the observations of
MRP in human erythrocytes [17,18]. The inhibitory
constant (IC50) for MK571 of approx. 0.1 WM, ob-
tained in the present study, is similar to that reported
previously for human erythrocytes [18].
GSSG and S-conjugates of glutathione are sub-
Fig. 6. The e¡ect of Mg2, Mn2 and Co2 on the uptake (left panel) and binding (right panel) of cGMP to inside-out vesicles after
120 min co-incubation at 37‡C. Mg2 (b), Mn2 (R) and Co2 (F) were added at concentrations from 1 to 20 mM together with
1 WM [3H]cGMP with or without 1 mM ATP. The results are presented as mean values of ¢ve separate experiments.
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strates for various members of the MRP family [19].
In human erythrocytes MRP has been identi¢ed as a
glutathione S-conjugate transporter [18]. The most
potent conjugate in the present study was SDG
which caused a half-maximal inhibition at about 40
WM. This compound has been reported to inhibit
LTC4 transport with a Ki of 50^120 nM [16,22].
Furthermore, GSSG inhibited cGMP uptake with a
IC50 value of about 2 mM, but LTC4 transport with
Ki values of 0.1 mM [16,22]. Taken together these
observations support the idea that the cGMP trans-
porter is di¡erent from MRP. However, human er-
ythrocytes possess several transport systems for glu-
tathione conjugates [23] and the cGMP transport
system appears to be a type of GS-X pump.
The two sulfhydryl protecting agents GSH and
DTT inhibited cGMP egression similarly at high
concentrations. This e¡ect may be explained by a
protection of sulfhydryl groups at the membrane en-
doside since DTT, but not GSH, is membrane per-
meable. The recently reported e¡ect of NEM [9] sug-
gests a role for sulfhydryl groups in the regulation of
the cGMP transport.
In agreement with previous reports [1,6], the
present study showed that the transport of cGMP
was temperature sensitive and with no detectable
transport below 18^20‡C. This is unlike the transport
of dinitrophenyl-glutathione where a signi¢cant ac-
tivity was observed at 20‡C [24,25].
On the other hand, the ATP-independent associa-
tion of cGMP to the inside-out vesicles was not tem-
perature dependent. We de¢ne this component as
binding, and not passive di¡usion, since (a) concen-
tration gradients between 100 and 1000 were needed
to load intact erythrocytes with cGMP [6], (b) a rap-
id equilibrium occurs (within 15 min at 37‡C) and (c)
the association rate is markedly slowed down at low
temperature (0^4‡C). This binding may represent
speci¢c (such as binding to active sites of the
cGMP pump, phosphodiesterases or protein kinases)
or non-speci¢c interactions.
Transport ATPases are dependent on pH and may
be characteristic for the individual enzyme [26]. The
present study showed that the high a⁄nity transport
of cGMP has a pH optimum at pH 8.0^8.5. This is
similar to that reported for dinitrophenyl-glutathione
transport [24,27,28], but in contrast to the transport
system for GSSG with an optimum at acidic pH [29].
Calcium has a regulatory function in a variety of
cellular processes, including ATP-dependent trans-
port systems [26] and inhibits the transport of dini-
trophenyl-glutathione with an IC50 value of about
0.7 WM [28]. A markedly lower sensitivity to calcium
(IC50 value of about 40 WM) was found for cGMP
uptake to inside-out vesicles. However, both these
values are above the normal cytosolic free calcium
concentrations (about 100 nM). In contrast to the
present observation, incubation of liver slices with
the Ca2 ionophore A23187 [5] and platelets with
thapsigargin, that inhibits ER Ca2 ATPases and
thereby increases intracellular Ca2 [30], leads to in-
creased extracellular cGMP levels. The reasons for
these apparently con£icting results are not clear.
Fig. 7. The e¡ect of EDTA and EGTA on the uptake of
cGMP to inside-out vesicles after 120 min co-incubation at
37‡C. Concentrations of the divalent ions from 0.01 to 100 mM
were added together with 1 WM [3H]cGMP with or without
1 mM ATP. The results are presented as mean values of three
and four separate experiments for EDTA (b) and EGTA (F),
respectively.
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Magnesium is a well-known activator of various
ATPases, but other divalent cations may, at least
partly, substitute Mg2 to maintain enzyme activity
[26]. Recently, we showed that ATP energised the
cGMP transport with a Km value of 0.3^0.5 mM
and that Mg2 caused an activation of transport
for concentrations up to 10 mM [9]. The present
study veri¢es this e¡ect of Mg2 and shows clearly
that Mn2 and Co2 were unable to substitute Mg2
and the low intracellular concentrations of Mn2 and
Co2 make their role as regulators of little relevance.
Similar, but not identical results were obtained in a
study of P-glycoprotein [31].
Another di¡erence was that Mn2/Co2 were po-
tent inhibitors of cGMP binding to membrane endo-
side, whereas Mg2 had no e¡ect. If the binding of
cGMP re£ects an interaction with the cGMP trans-
port binding site, the e¡ect of Mn2/Co2 could ex-
plain the transport inhibition at the highest concen-
trations.
EDTA is a chelator with a⁄nity for both Ca2
and Mg2, whereas EGTA is relatively calcium-spe-
ci¢c. The present study revealed that both EGTA
and EDTA enhanced cGMP e¥ux. On the back-
ground of the present observed Ca2 and Mg2 ef-
fects, it is conceivable that the apparent stimulatory
e¡ect of chelators is an indirect e¡ect due to Ca2
binding. The source of Ca2 in the present experi-
ments is unclear, since no such was added, but re-
lease from cell membrane stores or impurities within
the chemicals or solvents are possible explanations.
The ¢nal e¡ect of EDTA is a result of reduced stim-
ulation by binding of Mg2 and reduced inhibition
by binding of Ca2. This may explain why EDTA is
less potent than EGTA. The ATPase responsible for
cGMP egression must be di¡erent from Ca2 ATP-
ases since EGTA is referred to as a relatively speci¢c
inhibitor of these. The present observation of a stim-
ulatory e¡ect of EGTA on cGMP transport is in
close agreement with a recent report [9].
In conclusion, the present study shows that the
cGMP transport is dependent on an ATPase with
characteristics typical for other transport/tra⁄c
ATPases (sensitive to temperature and pH, and regu-
lated by divalent cations). Although the cGMP
transporter has properties similar to that of gluta-
thione conjugate transporters (GS-X pumps), it is
di¡erent from MRP.
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